ALFA Finder
11:57 IST
NSE
Earnings Call
Sai Life Science Earnings Call Transcript: Key Takeaways
Q2 revenue up 23% YoY, H1 up 17%, EBITDA margin steady at 28%. Management deflected on H2 figures, capacity timing and revenue visibility.
Sai Life Science Ltd
- Share price
- ₹1,918.60
- Market cap
- ₹40,786 Cr
- Revenue (annual)
- ₹2,192 Cr
- Net profit (annual)
- ₹348.9 Cr
- P/E (TTM)
- 108.4×Sector 43.8×
- Promoter holding
- 34.50%-0.03% QoQ
- FII holding
- 19.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
00:15 IST
NSE
Earnings Call
Sai Life Science Investor Presentation: Key Takeaways
H1 FY27 revenue ₹1,213 Cr (+17% YoY), EBITDA ₹335 Cr (28% margin), PAT ₹172 Cr (+19%). Q2 revenue ₹659 Cr (+23%). Strategy: integrated CRDMO, larger strategic pharma engagements, ₹621 Cr H1 capex.
00:12 IST
NSE
Results Update
Sai Life Science Results Update
Sai Life Sciences posted Q2 FY27 revenue growth of 23% YoY, with H1 PAT up 19% to ₹172 Cr. The company incurred ₹621 Cr capex in H1.
23:14 IST
BSE
Employee Stock Options
Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
23:11 IST
BSE
Management Change
Sai Life Science Management Change
Sai Life Sciences appointed three senior management personnel effective 5 November 2026. The appointees include Sidhartha Das as Senior Vice President and Head of Human Resources.
22:48 IST
BSE
Financial Results
Sai Life Science Q2 FY27 Results: Net Profit ₹98.3 Cr, Up 17.3% YoY
Sai Life Science Ltd reported revenue from operations of ₹658.6 Cr (+22.5% YoY) and net profit of ₹98.3 Cr (+17.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹98.3 Cr · +17.3% YoY